| European Case Law Identifier: | ECLI:EP:BA:2016:T127210.20160711 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 11 July 2016 | ||||||||
| Case number: | T 1272/10 | ||||||||
| Application number: | 03007948.7 | ||||||||
| IPC class: | A61K 39/39 A61K 9/00 C12N 15/11 A61K 39/00 A61K 38/16 A61K 39/02 A61K 39/106 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Use of skin penetration enhancers and barrier disruption agents to enhance transcutaneous immune response | ||||||||
| Applicant name: | The Government of the United States, as represented by Secretary of the Army |
||||||||
| Opponent name: | Sagittarius Intellectual Property Consultants Ltd | ||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Lapse of patent in all designated states - continuation of appeal proceedings (no) | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t101272eu1.html
Date retrieved: 17 May 2021
6 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.EPC Implementing Rules
XR.84 EPC Continuation of the opposition proceedings by the European Patent Office of its own motion